JBMRPlus Profile Banner
JBMRPlus Profile
JBMRPlus

@JBMRPlus

Followers
1K
Following
404
Media
555
Statuses
834

JBMR® Plus, @ASBMR's open access journal, serves the diverse community in bone, mineral and musculoskeletal research. Editor-in-Chief: @dveislab

Joined April 2022
Don't wanna be here? Send us removal request.
@JBMRPlus
JBMRPlus
7 months
The February issue of JBMR Plus is now available! Don’t miss this month’s Special Collection on Rare Musculoskeletal Diseases 2024. Read more here:
Tweet media one
0
2
5
@JBMRPlus
JBMRPlus
8 months
New findings in #JBMRPlus build on the potential that Lipocalin-2 (LCN2) can be used as a biomarker for chronic disease and whether exercise can mitigate age-related disease associated with LCN2 changes. @carlie_bauer1. Read more here:
Tweet media one
0
0
1
@grok
Grok
6 days
Join millions who have switched to Grok.
86
155
1K
@JBMRPlus
JBMRPlus
8 months
The January Issue of #JBMRPlus is now available! All articles are #openaccess #freetoread @ASBMR @OUPMedicine . Read it here:
Tweet media one
0
0
1
@JBMRPlus
JBMRPlus
8 months
Happy New Year! Thinking about your professional new year’s resolutions? Is “finish manuscript” on the list? Submit to @JBMRPlus in 2025 for fair and prompt reviews and open communication with the editors. All articles are #openaccess & #freetoread.@ASBMR.
Tweet media one
0
0
5
@JBMRPlus
JBMRPlus
8 months
The entire team at @JBMRPlus wishes our authors, editors, reviewers, and readers a safe and happy holiday season!
0
0
3
@JBMRPlus
JBMRPlus
8 months
Congratulations! Here is the highest-cited paper published in 2024:.#Romosozumab added to ongoing #denosumab in postmenopausal #osteoporosis, a prospective observational study .@DrGiovanniAdami.@ASBMR @OUP_Medicine
Tweet media one
0
3
6
@JBMRPlus
JBMRPlus
8 months
The entire team at @JBMRPlus wishes our authors, editors, reviewers, and readers a safe and happy holiday season!
0
0
6
@JBMRPlus
JBMRPlus
8 months
New findings in #JBMRPlus emphasize the significant role of comorbidities in influencing cardiovascular outcomes during romosozumab treatment, adding to the current body of safety data on romosozumab. @ASBMR @OUP_Medicine.Read more here:
Tweet media one
0
1
3
@JBMRPlus
JBMRPlus
8 months
Congratulations! Here is the highest Altmetrics-scoring paper of 2024: Postfracture survival in a population-based study of adults aged ≥66 yr: a call to action at hospital discharge
Tweet card summary image
academic.oup.com
Abstract. Postfracture survival rates provide prognostic information but are rarely reported along with other mortality outcomes in adults aged ≥50 yr. The
0
1
3
@JBMRPlus
JBMRPlus
9 months
Congratulations! 📣 The most read paper published in 2024 is Iron and bones: effects of iron overload, deficiency and anemia treatments on bone, by Felix N von Brackel and Ralf Oheim.@ASBMR @OUP_Medicine
Tweet media one
0
1
9
@JBMRPlus
JBMRPlus
9 months
Explore the new highly cited collection from #JBMRPlus! Featuring ground-breaking research on muscle, joint, rare bone disease, and studies that add to our knowledge and advance global musculoskeletal health. @ASBMR @OUP_Medicine
Tweet media one
0
1
2
@JBMRPlus
JBMRPlus
9 months
Despite advancements in medical imaging technologies, precision error still exists. Results in this #JBMRPlus article suggest that operators effectively control precision factors, leading to consistency @Zebaze1R @DavidScottPhD @DrAyseZ. Read more here:
Tweet media one
0
0
1
@JBMRPlus
JBMRPlus
9 months
Researchers in this study in #JBMRPlus measure how factors like age, being male or female, amount of calcification, and location in the rib cage affect the bending stiffness of costal cartilage as a whole and as a material @OUPMedicine. Read more here:
Tweet media one
0
0
1
@JBMRPlus
JBMRPlus
9 months
A new article in #JBMRPlus report the first case of a woman with twin pregnancy and osteogenesis imperfecta (OI) type I who presented with multiple vertebral #fractures following delivery and post-partum lactation @Zebaze1R.#openaccess. Read more here:
Tweet media one
0
1
4
@JBMRPlus
JBMRPlus
9 months
The December issue of #JBMRPlus is now available! Read more here: All articles are #openaccess and #freetoread.@ASBMR @OUPMedicine
Tweet media one
0
0
3
@JBMRPlus
JBMRPlus
9 months
Understanding fibroblast growth factor 23 (FGF23) physiology and pathology helped identify the exact source of excess FGF23 secretion in a new osteomalacia case in #JBMRPlus. @ASBMR.@OUPMedicine. Read more here:
Tweet media one
0
2
3
@JBMRPlus
JBMRPlus
9 months
Results in this #JBMRPlus article on how indoxyl sulfate (IS) may target the osteocytes leading to bone cell uncoupling in renal osteodystrophy suggest that IS elevation in patients with chronic kidney disease can cause bone damage @ASBMR. Read more here:
Tweet media one
0
1
1
@JBMRPlus
JBMRPlus
10 months
Findings in this #JBMRPlus article suggest that osteocytes potentially play a significant role in the post-traumatic systemic response to fracture, though the effects differ between trabecular and cortical bone @benosipov1 @OrrScience. Read more here:
Tweet media one
0
2
4
@JBMRPlus
JBMRPlus
10 months
This study in #JBMRPlus compares the effect of romosozumab and bisphosphonate administration on subsequent vertebral fractures after balloon kyphoplasty and identifies factors associated with occurrences of subsequent vertebral fractures. Read more here:
Tweet media one
0
0
0
@JBMRPlus
JBMRPlus
10 months
Researchers in this #JBMRPlus article report that hip geometry and strength parameters remained stable during the first year after kidney transplantation irrespective of bisphosphonate use. @markushovd @OUPMedicine @ASBMR. Read more here:
Tweet media one
0
1
3